Participants 0 134 3
Bevacizumab-augmented retinal laser photocoagulation in proliferative diabetic retinopathy: a randomized double-masked clinical trial.
Participants 320 494 6
METHODS A prospective, fellow-eye sham controlled clinical trial was conducted on 80 eyes of 40 high-risk characteristic proliferative diabetic retinopathy type II diabetics.
Participants 911 1000 6
RESULTS The median age was 52 years (range: 39-68) and 30% of the participants were male.
